We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.02B
AUM Growth
+$74.7M
Cap. Flow
-$986K
Cap. Flow %
-0.1%
Top 10 Hldgs %
31.61%
Holding
254
New
10
Increased
66
Reduced
77
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.43M
2
QCOM icon
Qualcomm
QCOM
+$1.65M
3
BX icon
Blackstone
BX
+$1.52M
4
DIS icon
Walt Disney
DIS
+$869K
5
ZTS icon
Zoetis
ZTS
+$790K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.24M
2
BA icon
Boeing
BA
+$1.45M
3
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$1.35M
4
XOM icon
ExxonMobil
XOM
+$1.3M
5
AGN
Allergan plc
AGN
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 20.13%
2 Technology 16.35%
3 Financials 15.15%
4 Industrials 12.69%
5 Energy 8.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITA icon
101
iShares US Aerospace & Defense ETF
ITA
$14.7B
$1.6M 0.16%
14,370
+2,040
+17% +$229K
WY icon
102
Weyerhaeuser
WY
$18.4B
$1.51M 0.15%
49,900
-2,320
-4% -$67.3K
GE icon
103
GE Aerospace
GE
$384B
$1.49M 0.15%
26,828
-100
-0.4% -$5.17K
MNR
104
DELISTED
Monmouth Real Estate Investment Corp
MNR
$1.45M 0.14%
100,000
– –
CSX icon
105
CSX Corp
CSX
$93.1B
$1.41M 0.14%
58,614
– –
MKC icon
106
McCormick & Company Non-Voting
MKC
$14.2B
$1.41M 0.14%
16,600
+1,950
+13% +$161K
NEM icon
107
Newmont
NEM
$119B
$1.41M 0.14%
32,343
+300
+0.9% +$11.7K
CI icon
108
Cigna
CI
$74.6B
$1.38M 0.14%
6,738
– –
FLS icon
109
Flowserve
FLS
$10.2B
$1.36M 0.13%
27,258
– –
TD icon
110
Toronto Dominion Bank
TD
$200B
$1.27M 0.12%
22,700
-288
-1% -$16.3K
FTV icon
111
Fortive
FTV
$18.6B
$1.27M 0.12%
26,435
– –
GAM
112
General American Investors Company
GAM
$1.61B
$1.26M 0.12%
33,427
-5,207
-13% -$192K
XLRN
113
DELISTED
Acceleron Pharma
XLRN
$1.22M 0.12%
22,964
-10,000
-30% -$456K
DVN icon
114
Devon Energy
DVN
$47.3B
$1.17M 0.11%
45,000
– –
ENB icon
115
Enbridge
ENB
$112B
$1.1M 0.11%
27,735
– –
GS icon
116
Goldman Sachs
GS
$303B
$1.07M 0.1%
4,650
+800
+21% +$174K
WMT icon
117
Walmart Inc
WMT
$890B
$1.01M 0.1%
25,434
– –
SLRC icon
118
SLR Investment Corp
SLRC
$715M
$1M 0.1%
48,500
– –
DE icon
119
Deere & Co
DE
$168B
$988K 0.1%
5,700
-50
-0.9% -$8.61K
CNI icon
120
Canadian National Railway
CNI
$76.6B
$981K 0.1%
10,842
– –
CL icon
121
Colgate-Palmolive
CL
$74.4B
$972K 0.1%
14,111
– –
MRSH
122
Marsh
MRSH
$91.5B
$950K 0.09%
8,530
– –
PM icon
123
Philip Morris
PM
$295B
$949K 0.09%
11,150
-200
-2% -$16.5K
XLI icon
124
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
$944K 0.09%
11,585
+3,335
+40% +$266K
NVS icon
125
Novartis
NVS
$297B
$940K 0.09%
9,932
– –
3 4
5
6 7

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q4 2019 Portfolio in Review

As of Q4 2019, Neville Rodie & Shaw held 254 positions worth $1.02B, up 7.9% from $945M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Neville Rodie & Shaw's Q4 2019 filing shows 10 new, 66 increased, 77 reduced and 4 closed positions. Its largest new stake was Qualcomm: 19,730 shares worth $1.74M. The largest sale was Celgene Corp, an estimated $9.24M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • Neville Rodie & Shaw's largest Q4 2019 buy was Qualcomm: 19,730 shares worth $1.74M.
  • Neville Rodie & Shaw added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.43M increase.
  • Neville Rodie & Shaw's biggest Q4 2019 reduction was Boeing, cutting an estimated $1.45M.
  • Neville Rodie & Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $9.24M.
  • Neville Rodie & Shaw's ten largest holdings make up 32% of its $1.02B portfolio in Q4 2019.
  • Neville Rodie & Shaw opened 10 new positions and closed 4 in Q4 2019.
  • Neville Rodie & Shaw's portfolio value rose 7.9% quarter-over-quarter to $1.02B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2019, filed 8 Jan 2020.